Helus Pharma Inc

NAS:HELPHealthcareNASDAQ:NCXnasdaq_composite

$11.42+6.83%LiveIn session · ≈ AED 41.94 · Market cap $1.45M · Next earnings Thu 12 Nov

HELP · Ratios · TradingHolo

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	−36.0%	0.0%	0.0%	—	0.0%	100.3%	—	—
Operating margin	−3,592.0%	−38,053.2%	−20,523.9%	—	−30,310.4%	317.1%	317.1%	+0.0 pts
Net margin	−3,729.2%	−40,314.1%	−18,919.2%	—	−23,956.0%	329.1%	329.1%	+0.0 pts
EBITDA margin	−3,586.3%	−37,953.0%	−20,423.9%	—	−30,265.7%	316.8%	—	—
Return on equity	−37.4%	−88.8%	−98.5%	−26.7%	−47.7%	−63.3%	−63.3%	+0.0 pts
Return on assets	−35.0%	−80.5%	−88.1%	−25.9%	−43.7%	−58.4%	−58.4%	+0.0 pts
Return on capital employed	−35.6%	−83.8%	−106.8%	−27.0%	−60.3%	−60.9%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	—	—
Interest coverage	−3,103.5×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	13.6×	7.4×	4.1×	21.6×	7.7×	9.5×	9.5×	+0.0%
Quick ratio	13.6×	7.4×	4.1×	21.6×	7.7×	9.5×	—	—
Cash ratio	13.1×	6.8×	2.9×	20.7×	6.3×	8.1×	8.1×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	−0.2×	—	—
Receivables turnover	0.7×	0.1×	0.1×	0.0×	0.1×	−8.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.